NCI-60 is a group of 59 human cancer cell lines (originally 60) developed by the National Cancer Institute for screening purposes. Isolated from various tissues (bone marrow, lung, ovary, brain, skin, breast, colon, kidney, prostate), the cell lines are used extensively to screen experimental cancer drug compounds and study tumor development.